Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer

Title:Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer

Volume: 24 Issue: 7

Author(s): Shun Wan, Kun-peng Li, Chen-Yang Wang, Jian-wei Yang, Si-Yu Chen, Hua-Bin Wang, Xiao-ran Li*Li Yang*

Affiliation:

• Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, PR China
• Gansu Province Clinical Research Center for Urology, Lanzhou, 730000, PR China

• Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, PR China
• Gansu Province Clinical Research Center for Urology, Lanzhou, 730000, PR China

Keywords: Bladder cancer, endoplasmic reticulum stress, immune, immune cells, signal transduction, muscle-invasive bladder cancer.

Abstract: Bladder cancer (BC) is a common malignant tumor of the urinary system. While current approaches involving adjuvant chemotherapy, radiotherapy, and immunotherapy have shown significant progress in BC treatment, challenges, such as recurrence and drug resistance, persist, especially in the case of muscle-invasive bladder cancer (MIBC). It is mainly due to the lack of pre-existing immune response cells in the tumor immune microenvironment. Micro-environmental changes (such as hypoxia and under-nutrition) can cause the aggregation of unfolded and misfolded proteins in the lumen, which induces endoplasmic reticulum (ER) stress. ER stress and its downstream signaling pathways are closely related to immunogenicity and tumor drug resistance. ER stress plays a pivotal role in a spectrum of processes within immune cells and the progression of BC cells, encompassing cell proliferation, autophagy, apoptosis, and resistance to therapies. Recent studies have increasingly recognized the potential of natural compounds to exhibit anti-BC properties through ER stress induction. Still, the efficacy of these natural compounds remains less than that of immune checkpoint inhibitors (ICIs). Currently, the ER stress-mediated immunogenic cell death (ICD) pathway is more encouraging, which can enhance ICI responses by mediating immune stemness. This article provides an overview of the recent developments in understanding how ER stress influences tumor immunity and its implications for BC. Targeting this pathway may soon emerge as a compelling therapeutic strategy for BC.

Cite this article as:

Wan Shun, Li Kun-peng, Wang Chen-Yang, Yang Jian-wei, Chen Si-Yu, Wang Hua-Bin, Li Xiao-ran*, Yang Li*, Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer, Current Cancer Drug Targets 2024; 24 (7) . https://dx.doi.org/10.2174/0115680096272663231121100515